Association analysis of C6 genetic variations and aspirin hypersensitivity in Korean asthmatic patients

Human Immunology

Volumn 72, Issue 10, 2011, Pages 973-978

  Pasaje, Charisse Flerida A ^a   Bae, Joon Seol ^a   Park, Byung Lae ^b   Cheong, Hyun Sub ^b   Jang, An Soo ^c   Uh, Soo Taek ^c   Kim, Mi Kyeong ^d   Koh, In Song ^e   Kim, Jeong Hyun ^a   Park, Tae Joon ^a   Lee, Jin Sol ^a   Kim, Yongha ^a   Park, Choon Sik ^c   Shin, Hyoung Doo ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

Aspirin intolerant asthma; C6; Haplotype; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; COMPLEMENT COMPONENT C6;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; ASIAN; ASPIRIN EXACERBATED RESPIRATORY DISEASE; CONTROLLED STUDY; DRUG DOSE INCREASE; EXON; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; INTRON; KOREAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; CASE-CONTROL STUDIES; COHORT STUDIES; COMPLEMENT C6; DNA FINGERPRINTING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HAPMAP PROJECT; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS;

EID: 80052971514     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.022     Document Type: Article

References (43)

1. Babu K.S., Salvi S.S. Aspirin and asthma. Chest 2000, 118:1470-1476.
2. Szczeklik A., Sanak M. Molecular mechanisms in aspirin-induced asthma. Allergy Clin Immunol Int 2000, 12:171-176.
3. Hedman J., Kaprio J., Poussa T., Nieminen M.M. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722.
4. Kasper L., Sladek K., Duplaga M., Bochenek G., Liebhart J., Gladysz U., et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy 2003, 58:1064-1066.
5. Stevenson D.D. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984, 74:617-622.
6. Samter M., Beers R.F. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968, 68:975-983.
7. Pasaje C.F., Kim J.H., Park B.L., Cheong H.S., Chun J.Y., Park T.J., et al. Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population. Ann Hum Genet 2010, 74:326-334.
8. Kim J.Y., Kim J.H., Park T.J., Bae J.S., Lee J.S., Pasaje C.F., et al. Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: A case-case study. BMC Pulm Med 2010, 10:34.
9. Lee J.S., Kim J.H., Bae J.S., Kim J.Y., Park T.J., Pasaje C.F., et al. Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population. BMC Med Genet 2010, 11:138.
10. Kim J.H., Park B.L., Cheong H.S., Bae J.S., Park J.S., Jang A.S., et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS ONE 2010, 5:e13818.
11. Leenaerts P.L., Stad R.K., Hall B.M., Van Damme B.J., Vanrenterghem Y., Daha M.R. Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol 1994, 97:478-482.
12. Orren A., Wallace M.E., Hobart M.J., Lachmann P.J. C6 polymorphism and C6 deficiency in site strains of the mutation-prone Peru-Coppock mice. Comp Inflamm 1989, 6:295-296.
13. Esser A.F. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 1994, 87:229-247.
14. Van Zele T., Coppieters F., Gevaert P., Holtappels G., Van Cauwenberge P., Bachert C. Local complement activation in nasal polyposis. Laryngoscope 2009, 119:1753-1758.
15. Medzhitov R., Janeway C.A. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997, 91:295-298.
16. Stimler-Gerard N.P. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses. Complement 1986, 3:137-151.
17. Legler D.F., Loetscher M., Jones S.A., Dahinden C.A., Arock M., Moser B. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur J Immunol 1996, 26:753-758.
18. DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 1999, 162:1127-1136.
19. Delaney J.C., Kay A.B. Complement components and IgE in patients with asthma and aspirin idiosyncrasy. Thorax 1976, 31:425-427.
20. Hänsch G.M., Voigtländer V., Rother U. Effect of aspirin on the complement system in vitro. Int Arch Allergy Appl Immunol 1980, 61:150-158.
21. Lee S.H., Rhim T., Choi Y.S., Min J.W., Kim S.H., Cho S.Y., et al. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006, 173:370-378.
22. Kurz T., Hoffjan S., Hayes M.G., Schneider D., Nicolae R., Heinzmann A., et al. Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J Allergy Clin Immunol 2006, 118:396-402.
23. Ober C., Cox N.J., Abney M., Di Rienzo A., Lander E.S., Changyaleket B., et al. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet 1998, 7:1393-1398.
24. Crapo R.O., Casaburi R., Coates A.L., Enright P.L., Hankinson J.L., Irvin C.G., et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000, 161:309-329.
25. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
26. Morris J.F. Spirometry in the evaluation of pulmonary function. West J Med 1976, 125:110-118.
27. Cormican L.J., Farooque S., Altmann D.R., Lee T.H. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin Exp Allergy 2005, 35:717-722.
28. Livak K.J. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999, 14:143-149.
29. Makridakis N.M., Reichardt J.K. Multiplex automated primer extension analysis: Simultaneous genotyping of several polymorphisms. Biotechniques 2001, 31:1374-1380.
30. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
31. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769.
32. Marquette C.H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J.M., et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992, 146:76-81.
33. Picado C., Castillo J.A., Montserrat J.M., Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989, 2:127-129.
34. Trotter C.M., Orr T.S. A fine structure study of some cellular components in allergic reactions. 1. Degranulation of human mast cells in allergic asthma and perennial rhinitis. Clin Allergy 1973, 3:411-425.
35. Nomura A., Uchida Y., Sakamoto T., Ishii Y., Masuyama K., Morishima Y., et al. Increases in collagen type I synthesis in asthma: The role of eosinophils and transforming growth factor-beta. Clin Exp Allergy 2002, 32:860-865.
36. Shum B.O., Rolph M.S., Sewell W.A. Mechanisms in allergic airway inflammation-lessons from studies in the mouse. Expert Rev Mol Med 2008, 10:e15.
37. Wills-Karp M. Complement activation pathways: A bridge between innate and adaptive immune responses in asthma. Proc Am Thorac Soc 2007, 4:247-251.
38. Watson J.W., Drazen J.M., Stimler-Gerard N.P. Synergism between inflammatory mediators in vivo. Induction of airway hyperresponsiveness to C3a in the guinea pig. Am Rev Respir Dis 1988, 137:636-640.
39. Hänsch G.M., Römer W., Voigtländer V., Rother U. Effect of salicylates on the complement system: Generation of mediators in vivo and in vitro. Clin Immunol Immunopathol 1981, 21:228-236.
40. Varghese M., Lockey R.F. Aspirin-exacerbated asthma. Allergy Asthma. Clin Immunol 2008, 4:75-83.
41. Eid NA, Hussein AA, Elzein AM, Mohamed HS, Rockett KA, Kwiatkowski DP, et al. Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: The effect of sub-structuring. Malar J;9:119.
42. Pagani F., Baralle F.E. Genomic variants in exons and introns: Identifying the splicing spoilers. Nat Rev Genet 2004, 5:389-396.
43. Maquat L.E. The power of point mutations. Nat Genet 2001, 27:5-6.